Butaclamol
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(3S,4aS,13bS)-3-(2-Methyl-2-propanyl)-2,3,4,4a,8,9,13b,14-octahydro-1H-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol
|
|
| Identifiers | |
| CAS Number | 36504-93-5 |
| ATC code | None |
| PubChem | CID 37459 |
| IUPHAR/BPS | 62 |
| ChemSpider | 34364 |
| UNII | A7A2802VNL  |
| ChEBI | CHEBI:73298 |
| ChEMBL | CHEMBL479587 |
| Chemical data | |
| Formula | C25H31NO |
| Molar mass | 361.52 g/mol |
|
Butaclamol (AY-23,028) is an antipsychotic which was never marketed.[1] Sold as the hydrochloride salt for use in research, the compound acts as a dopamine receptor antagonist.[2]
Chemistry[edit]
pKa = 7.15 (uncorrected for ionic strength)[3]
See also[edit]
References[edit]
- ^ Buckingham, J. Dictionary of organic compounds - Google Books. ISBN 9780412540905.
- ^ http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&N4=D033%7CSIGMA&N25=0&QS=ON&F=SPEC
- ^ F. A. Chrzanowski, B. A. McGrogan, B. E. Maryanoff (1985). "The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors." J. Med. Chem. 28 399-400.
|
|
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
